Literature DB >> 19528481

Riluzole induces apoptotic cell death in human prostate cancer cells via endoplasmic reticulum stress.

Kanako Akamatsu1, Masa-Aki Shibata, Yuko Ito, Yoshiro Sohma, Haruhito Azuma, Yoshinori Otsuki.   

Abstract

BACKGROUND: Ion channel modulators have been previously associated with cell proliferation and cell death in human cancer cell lines.
MATERIALS AND METHODS: The effects of riluzole, an ion channel modulator, on cell proliferation, apoptosis and the apoptotic pathway in the LNCaP and C4-2 prostate cancer cell lines were investigated.
RESULTS: Riluzole inhibited DNA synthesis and increased apoptotic cells in both cell lines. The activities of caspase-3, -8 and -9 were significantly increased, and caspase inhibitors for caspase-3, -8 and -9 significantly rescued the cell viability of both carcinoma cell lines treated with riluzole. However, a change in mitochondrial membrane potential, release of cytochrome c and cleavage of Bid were not observed in the riluzole-treated cells. Riluzole significantly induced elevation of caspase-4 activity, fluorescence indicating cytosolic calcium, and morphological changes in endoplasmic reticulum (ER) as observed by transmission electron microscopy.
CONCLUSION: Riluzole induces inhibition of DNA synthesis and apoptotic cell death via ER stress in both the LNCaP and C4-2 prostate cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528481

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.

Authors:  Cecilia L Speyer; Miriam A Bukhsh; Waris S Jafry; Rachael E Sexton; Sudeshna Bandyopadhyay; David H Gorski
Journal:  Breast Cancer Res Treat       Date:  2017-08-05       Impact factor: 4.872

2.  Targetable Clinical Nanoparticles for Precision Cancer Therapy Based on Disease-Specific Molecular Inflection Points.

Authors:  Charalambos Kaittanis; Alexander Bolaender; Barney Yoo; Nilesh Shah; Ouathek Ouerfelli; Jan Grimm
Journal:  Nano Lett       Date:  2017-10-23       Impact factor: 11.189

3.  WJ9708012 exerts anticancer activity through PKC-α related crosstalk of mitochondrial and endoplasmic reticulum stresses in human hormone-refractory prostate cancer cells.

Authors:  Ting-chun Kuo; Wei-jan Huang; Jih-hwa Guh
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

4.  Effect of glutamate and riluzole on manganese-induced apoptotic cell signaling in neuronally differentiated mouse P19 Cells.

Authors:  Jerome A Roth; Swetha Sridhar; Steven T Singleton
Journal:  Neurochem Int       Date:  2012-04-21       Impact factor: 3.921

Review 5.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

6.  The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages.

Authors:  Sham Rampersaud; Justin Fang; Zengyan Wei; Kristina Fabijanic; Stefan Silver; Trisha Jaikaran; Yuleisy Ruiz; Murielle Houssou; Zhiwei Yin; Shengping Zheng; Ayako Hashimoto; Ayuko Hoshino; David Lyden; Shahana Mahajan; Hiroshi Matsui
Journal:  Nano Lett       Date:  2016-11-10       Impact factor: 11.189

7.  Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping.

Authors:  Darragh G McArt; Shu-Dong Zhang
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

8.  Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.

Authors:  Zarina Yelskaya; Vangie Carrillo; Ewa Dubisz; Hira Gulzar; Devon Morgan; Shahana S Mahajan
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

Review 9.  Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Int J Biol Sci       Date:  2013-08-09       Impact factor: 6.580

10.  Down-regulation of CHERP inhibits neuroblastoma cell proliferation and induces apoptosis through ER stress induction.

Authors:  Dunke Zhang; Feng Wang; Yi Pang; Xiao-Xue Ke; Shunqin Zhu; Erhu Zhao; Kui Zhang; Lixue Chen; Hongjuan Cui
Journal:  Oncotarget       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.